Search for Clinical Trial Results

Sponsored By

Eye Pain - 11 Studies Found

Status Study
Not yet recruiting Study Name: Study of SAF312 as an Eye Drop for Treatment of Eye Pain Following Photorefractive Keratectomy (PRK) Surgery
Condition: Postoperative Ocular Pain After PRK Surgery
Date: 2016-11-08
Interventions:
  • Drug: SAF312
  • Drug: Placebo
Completed Study Name: Evaluation of the Safety, Systemic Pharmacokinetics, and Tolerability
Condition: Eye Pain
Date: 2017-02-21
Interventions: Drug: Loteprednol Etabonate Ophthalmic Gel Formulated LE into a gel (loteprednol etabonate ophthalmic ge
Completed Study Name: Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular Pain
Condition:
  • Ocular Pain
  • Dry Eye Syndrome

Date: 2012-11-14
Interventions:
  • Drug: SYL1001 Ocular topical a
Completed Study Name: Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers
Condition:
  • Ocular Pain
  • Dry Eye

Date: 2011-09-14
Interventions: Drug: SYL1001 SYL1001 eye drops. topical administration
Completed Study Name: Dose-finding Study to Assess the Safety and Effect of SYL1001 in Patients With Ocular Pain
Condition:
  • Ocular Pain
  • Dry Eye Syndrome

Date: 2015-05-20
Interventions:
  • Drug: SYL1001 SYL1001 eye drop
Completed Study Name: Pain Expression in the Perioperative Period of Cataract Surgery
Condition:
  • Cataract
  • Surgery
  • Eye Pain Date: 2013-04-02
    Interventions:
    • Procedure: First eye (FE) Phac
Completed Study Name: Nepafenac Compared to Placebo for Ocular Pain and Inflammation
Condition: Cataract
Date: 2011-08-30
Interventions:
  • Drug: Nepafenac Ophthalmic Suspension, 0.1%

Completed Study Name: Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo
Condition: Cataracts
Date: 2006-11-29
Interventions:
  • Drug: Nepafenac 1mg/ml eye drops, suspension

Completed Study Name: RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD
Condition:
  • Corneal Endothelial Cell Loss
  • Ocular Pain
  • Drug: Placebo Opthalmic suspen
Recruiting Study Name: Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
Condition: Optic Neuritis
Date: 2015-08-10
Interventions:
  • Drug: Clemastine 12mg (4mg 3x/
Next >>>